Caris & Company

Analysts at Caris & Company maintain their "buy" rating on Bally Technologies (NYSE: BYI), while reducing their estimates for the company. The target price for BYI has been reduced from $58 to $56. Bally has reduced its EPS guidance for FY10 citing weaker-than-expected replacement demand, “...

Analysts at Caris & Company maintain their "buy" rating on Salix Pharmaceuticals (NASDAQ: SLXP). The target price for SLXP has been raised from $40 to $47. According to Caris & Company, SLXP’s IBS trial was better than expected. There is a high possibility of Xifaxan being approved to treat...

Analysts at Caris & Company maintain their "average" rating on Semtech Corp (NASDAQ: SMTC), while raising their estimates for the company. The target price for SMTC is set to $18. Semtech has announced robust results. “Shares added 4.5% aftermarket as investors digested: a) broad-based strength...

Caris & Company analyst Dorothy Lakner reiterated her Buy rating for shares of American Eagle Outfitters, Inc. (NYSE: AEO) with a price target of $23. Lakner wrote that American Eagle Outfitters was positioning itself to capitalize on the greater opporunities in the women's and children's...

Analysts at Caris & Company initiate coverage of HealthSouth (NYSE: HLS) with a "buy" rating. The target price for HLS is set to $24. According to Caris & Company, HLS is an attractive investment avenue due to its strong cash flow and discipline in operational focus. HLS’s shares gained 1....

Analyst Laura Champine of Caris & Company reiterates her "outperform" rating on Gap (NYSE: GPS), while raising her estimates for the company. According to Caris & Company, store checks indicate that GPS has offered only limited discounting in its Gap segment. Although low discounting will...

Analyst Phil Nadeau of Caris & Company reiterates his "outperform" rating on Gilead Sciences (NASDAQ: GILD), while raising his estimates for the company. According to Caris & Company, GILD reported robust Q4 results, with total revenues and non-GAP EPS exceeding the estimates and the...

According to a report released by Caris & Company, Cymer Inc. (NASDAQ: CYMI) is likely to report its earnings for Q4Y09 in sync with the research firm’s estimates. The research firm has predicted the Q4 EPS figure for Cymer Inc. at $0.34 and revenue at $94 million. Market estimates are at $0....

According to the analysts with Caris & Company, Netflix Inc. (NASDAQ: NFLX) is expected to report its Q4Y09 results slightly above the research firm’s estimates. The research firm has pegged the revenues at $447 million and EPS at $0.48. Market consensus for revenue is at $445.6 million....

Analysts at Caris & Company reiterate their “buy” rating on Inter Parfums, Inc (NASDAQ: IPAR), while raising their estimates for the company. The target price for IPAR has been raised from $16 to $18. Inter Parfums has signed a 10.5 year license agreement with Montblanc to create, produce and...

Caris & Company recently covered TiVo Inc. (Nasdaq: TIVO) in a report, reiterating its "2*/Above Average" rating of the company and setting a price target of $13.50. Caris noted that a recent lawsuit filed against TIVO had little merit and was a legal cover by Microsoft Corporation (Nasdaq:...

Zumiez Inc. (NASDAQ: ZUMZ) raised its 4Q EPS guidance to $0.24-$0.27 from the earlier $0.18-$0.22, after a +0.3% comp in December, its first positive monthly comp since August 2008. Value offerings, especially in men’s accessories and shoes have driven Zumiez’s sales, which saw the highest...

Analysts at Caris & Company reiterate their “buy” rating on American Eagle Outfitters (NYSE: AEO). The target price is set to $23. AEO posted its November comps at -2%, exceeding the estimates. According to Caris & Company, this is positive news, especially since several of AEO’s peers...

Caris & Company upgraded salesforce.com (NYSE: CRM) to “above average.” The target price for CRM has been raised from $47 to $68. Caris & Company believes CRM will post its revenues and EPS for Q310 slightly ahead of the consensus. CRM may also post improvement in its bookings and...